Su Zhen 4
4 · CytomX Therapeutics, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Su Zhen
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-11+38,000→ 38,000 totalExercise: $2.82Exp: 2035-06-10→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.